Himachal: Ill-Equipped Lab Blunts Fight Against Spurious Drugs

Solan : The absence of a well-equipped drugs testing laboratory in the state is acting as a major impediment to timely testing of drug samples.

The drugs control administration here depends on the Chandigarh-based Regional Drugs Testing Laboratory and its “ill-equipped” Kandaghat-based Composite Testing Laboratory (CTL) for testing samples collected from 660 drug firms. Since the Chandigarh laboratory caters to several states, it takes around two months to test a drug sample.

This not only delays prompt action against those manufacturing substandard and spurious drugs, but also blunts the fight against the manufacturing of spurious drugs.

Drug inspectors draw samples from various firms every month, but the delay in the receipt of test reports delays the regulatory action.

Figures secured from the Drugs Control Administration revealed that 204 manufacturing premises were inspected in 2018-19, 195 in 2019-2020, 168 in 2020-21 and 300 in 2021-22. Fifty manufacturing licences were suspended or cancelled during this period for various violations.

As against 158 drug samples declared substandard by the Central Drugs Standard Control Organisation in 2022, the state authorities could barely detect only 32 such drugs. Absence of a well-equipped testing laboratory is said to be the underlying reason.

The state drug control administration has declared only 74 drug samples as substandard or spurious in the state over the past three years (2020 to 2022). Legal action has been initiated in 17 of these cases, while administrative action was taken in other cases. Since the state houses a big pharmaceutical hub in the Baddi-Barotiwala-Nalagarh area, detection of substandard or spurious drugs has been besmirching its image nationally.

Drugs Controller Navneet Marwaha said, “The Baddi-based drugs testing laboratory will be functional soon as majority of the equipment has been installed. Its validation and calibration is underway. Two-three sophisticated machines are in the process of being installed.” Some technical staff had also been deputed, he added.

The drugs control administration depends on the Chandigarh-based Regional Drugs Testing Laboratory and Kandaghat-based Composite Testing Laboratory for testing samples collected from 660 drug firms. Since the Chandigarh laboratory caters to several states, it takes around two months to test a drug sample.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’